Pfizer CEO rules out generic COVID drug Paxlovid for China
Jan 9 (Reuters) - Pfizer Inc (PFE.N) is not in talks with Chinese authorities to license a generic version of its COVID-19 treatment Paxlovid for use there, but is in discussions about a price for the branded product, Chief Executive…